Single Cell Genome Sequencing Market Segmentation:
Type Segment Analysis
The instruments segment is projected to garner the largest revenue share of 59.5% in the market during the forecast timeline. The dominance of this subtype is effectively attributed to the continued innovations in high-throughput sequencing platforms for clinical and research environments. NIH in August 2022 revealed that FACS is widely used for marker-based sorting but requires high cell numbers and may cause cellular damage. Besides, microfluidic platforms, such as droplet-based systems, offer high-throughput, precise separation with integrated amplification, reducing pipetting errors and improving efficiency, hence a wider segment scope.
Technology Segment Analysis
Next-generation sequencing segment is expected to gain a share of 45.3% in the single cell genome sequencing market by the end of 2035. Cost efficiency, scalability, and capacity for deep genomic and transcriptomic profiling at the single-cell level are key factors behind this leadership. In July 2024, Thermo Fisher Scientific declared a partnership with the National Cancer Institute for the myeloMATCH precision medicine trial targeting AML and MDS. The initiative uses Thermo Fisher’s NGS technology for rapid genomic profiling of patient samples. Hence, this is the evidence for a wider market scope.
Disease Area Segment Analysis
Cancer segment is predicted to grow at a considerable rate with a share of 40.9% in the market during the discussed timeframe. This is an area of growth since single-cell sequencing unlocks tumor heterogeneity, driver mutations, and clonal evolution, which are highly essential for precision oncology. In February 2025, Takara Bio USA, Inc., a subsidiary of Takara Bio Inc., introduced two new single-cell NGS profiling technologies designed to advance oncology research. The newly launched Shasta Total RNA-Seq and Shasta Whole-Genome Amplification Kits offer high-throughput, automated solutions for single-cell transcriptome and genomic analysis.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Type |
|
|
Technology |
|
|
Disease Area |
|
|
Application |
|
|
Work Flow |
|
|
End use |
|
